Cargando…

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation

Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is general...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivo, C, Lecomte, C, Levy, F, Leroy, K, Kirova, Y, Renier, A, Kheuang, L, Piedbois, P, Chopin, D, Jaurand, M C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747542/
https://www.ncbi.nlm.nih.gov/pubmed/12569381
http://dx.doi.org/10.1038/sj.bjc.6600736
_version_ 1782172104567816192
author Vivo, C
Lecomte, C
Levy, F
Leroy, K
Kirova, Y
Renier, A
Kheuang, L
Piedbois, P
Chopin, D
Jaurand, M C
author_facet Vivo, C
Lecomte, C
Levy, F
Leroy, K
Kirova, Y
Renier, A
Kheuang, L
Piedbois, P
Chopin, D
Jaurand, M C
author_sort Vivo, C
collection PubMed
description Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However, the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry, and expression of cell cycle proteins, p53, p21(WAF1/CIP1) and p27(KIP1). In addition, we studied p53 gene mutations and expression of SV40 Tag. After exposure to γ-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a heterogeneity in cell cycle control. G1 arrest was p21(WAF1/CIP1)- and p53-dependent. Lack of arrest in G1 was not related to p53 mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to understand mesothelioma and develop new treatments.
format Text
id pubmed-2747542
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-27475422009-09-21 Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation Vivo, C Lecomte, C Levy, F Leroy, K Kirova, Y Renier, A Kheuang, L Piedbois, P Chopin, D Jaurand, M C Br J Cancer Molecular and Cellular Pathology Knowledge of the function of the cell cycle checkpoints in tumour cells may be important to develop treatment strategies for human cancers. The protein p53 is an important factor that regulates cell cycle progression and apoptosis in response to drugs. In human malignant mesothelioma, p53 is generally not mutated, but may be inactivated by SV40 early region T antigen (SV40 Tag). However, the function of p53 has not been investigated in mesothelioma cells. Here, we investigated the function of the cell cycle checkpoints in six human mesothelioma cell lines (HMCLs) by studying the cell distribution in the different phases of the cell cycle by flow cytometry, and expression of cell cycle proteins, p53, p21(WAF1/CIP1) and p27(KIP1). In addition, we studied p53 gene mutations and expression of SV40 Tag. After exposure to γ-radiation, HMCLs were arrested either in one or both phases of the cell cycle, demonstrating a heterogeneity in cell cycle control. G1 arrest was p21(WAF1/CIP1)- and p53-dependent. Lack of arrest in G1 was not related to p53 mutation or binding to SV40 Tag, except in one HMCL presenting a missense mutation at codon 248. These results may help us to understand mesothelioma and develop new treatments. Nature Publishing Group 2003-02-10 2003-02-10 /pmc/articles/PMC2747542/ /pubmed/12569381 http://dx.doi.org/10.1038/sj.bjc.6600736 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular and Cellular Pathology
Vivo, C
Lecomte, C
Levy, F
Leroy, K
Kirova, Y
Renier, A
Kheuang, L
Piedbois, P
Chopin, D
Jaurand, M C
Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title_full Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title_fullStr Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title_full_unstemmed Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title_short Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
title_sort cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation
topic Molecular and Cellular Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747542/
https://www.ncbi.nlm.nih.gov/pubmed/12569381
http://dx.doi.org/10.1038/sj.bjc.6600736
work_keys_str_mv AT vivoc cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT lecomtec cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT levyf cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT leroyk cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT kirovay cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT reniera cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT kheuangl cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT piedboisp cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT chopind cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation
AT jaurandmc cellcyclecheckpointstatusinhumanmalignantmesotheliomacelllinesresponsetogammaradiation